Skip to Content

TV 2134 (Minocycline Hydrochloride Extended-Release 65 mg)

Pill with imprint TV 2134 is Purple, Capsule-shape and has been identified as Minocycline Hydrochloride Extended-Release 65 mg. It is supplied by Teva Pharmaceuticals USA, Inc..

Minocycline is used in the treatment of bacterial infection; acne; bartonellosis; actinomycosis; bullous pemphigoid and belongs to the drug class tetracyclines. There is positive evidence of human fetal risk during pregnancy. Minocycline 65 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TV 2134

Minocycline hydrochloride extended-release 65 mg TV 2134

Minocycline Hydrochloride Extended-Release

Imprint
TV 2134
Strength
65 mg
Color
Purple
Size
16.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Tetracyclines
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA, Inc.
National Drug Code (NDC)
00093-2134
Inactive Ingredients
carnauba wax, silicon dioxide, hypromellose 2910 (6 mPa.s), lactose monohydrate, magnesium stearate, polyethylene glycol 3350, polyethylene glycol 4000, titanium dioxide, triacetin, D&C Red No. 27, aluminum oxide, FD&C Blue No. 2, indigotindisulfonate sodium, FD&C Red No. 40

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.